Harding, Lisa
Joshi, Kruti
Zhdanava, Maryia http://orcid.org/0000-0002-7995-2578
Shah, Aditi
Voegel, Arthur
Chen, Cindy
Pilon, Dominic
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
Article History
Accepted: 21 April 2024
First Online: 10 May 2024
Declarations
:
: This study was funded by Janssen Scientific Affairs, LLC, a Johnson & Johnson company.
: Part of the material in this article was presented at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, on May 30–June 2, 2023, as a poster presentation.
: Kruti Joshi and Cindy Chen are employees of Janssen Scientific Affairs, LLC, a Johnson & Johnson company, and are stockholders of Johnson & Johnson. Maryia Zhdanava, Aditi Shah, Arthur Voegel, and Dominic Pilon are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Janssen Scientific Affairs, LLC, a Johnson & Johnson company, which funded the development and conduct of this study and article. Lisa Harding reports the following details of compensated affiliation or involvement in an organization or entity with a financial or non-financial interest in the subject matter or materials discussed in this article: Janssen Neuroscience Advisory Panel on Mood Disorders and Speaker Bureau; Compass Pathways Advisory Panel on Mood Disorders; Takeda Pharmaceuticals Advisory Panel on Mood Disorders.
: MZ, AS, AV, and DP contributed to study conception and design, collection and assembly of data, and data analysis and interpretation. KJ, CC, and LH contributed to study conception and design and data analysis and interpretation. All authors reviewed and approved the final content of this article.
: Data were de-identified and comply with the patient requirements of the <i>Health Insurance Portability and Accountability Act</i> of 1996; therefore, no review by an institutional review board was required per Title 45 of CFR, Part 46.101(b)(4).
: The datasets generated and analyzed during the current study are not publicly available because they were used pursuant to a data use agreement. The data are available through requests made directly to Optum.
: Not applicable; our study was not a clinical trial and did not include patient identifiable information.